![James D. Luterman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James D. Luterman
Nessuna posizione attualmente
Profilo
James D.
Luterman worked as the Executive Vice President-Research & Development at OvaScience, Inc. from 2016 to 2018.
He received his undergraduate degree from Bucknell University and his doctorate degree from Rutgers State University of New Jersey.
Precedenti posizioni note di James D. Luterman
Società | Posizione | Fine |
---|---|---|
OvaScience, Inc.
![]() OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di James D. Luterman
Bucknell University | Undergraduate Degree |
Rutgers State University of New Jersey | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
OvaScience, Inc.
![]() OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- James D. Luterman